Inactive Instrument
Isodiol International Inc. Stock Canadian Securities Exchange
Stocks
ISOL
CA46500L2003
Pharmaceuticals
OTC Markets Traded| Market Cap | 3.91M 2.77M 2.42M 2.23M 2.06M 264M 3.98M 26.67M 10.47M 130M 10.39M 10.16M 447M | P/E 2018 |
-4.94x | P/E 2019 | -0.37x |
|---|---|---|---|---|---|
| Enterprise Value | 9.13M 6.46M 5.65M 5.21M 4.81M 616M 9.29M 62.27M 24.45M 304M 24.25M 23.73M 1.04B | EV / Sales 2018 |
12.6x | EV / Sales 2019 | 2.48x |
| Free-Float |
100% | Yield 2018 * |
-
| Yield 2019 | - |
| 1 day | +16.67% |
| Manager | Title | Age | Since |
|---|---|---|---|
Marcos Agramont
CEO | Chief Executive Officer | - | 2017-05-23 |
Andrew Alvis
DFI | Director of Finance/CFO | - | - |
| Corporate Officer/Principal | - | 2018-08-29 |
| Director | Title | Age | Since |
|---|---|---|---|
Marcos Agramont
BRD | Director/Board Member | - | 2017-05-23 |
| Director/Board Member | - | 2018-08-29 | |
| Director/Board Member | - | 2018-11-20 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +16.67% | +40.00% | - | - | 128 | |
| +0.95% | -0.08% | -12.93% | -8.65% | 12.85B | |
| +2.42% | +1.37% | -33.67% | -54.44% | 4.79B | |
| -0.02% | -0.64% | -7.44% | -9.65% | 4.4B | |
| +2.11% | -0.70% | +3.95% | -36.80% | 3.82B | |
| -7.84% | -7.31% | +11.66% | -7.74% | 3.68B | |
| -0.58% | +6.63% | -8.62% | -11.19% | 3.26B | |
| +0.28% | +0.57% | -11.17% | +4.30% | 3.1B | |
| -0.77% | +1.24% | -8.23% | -22.16% | 2.41B | |
| -0.32% | +4.78% | -5.15% | +45.77% | 1.8B | |
| Average | +1.29% | -1.14% | -7.95% | -11.17% | 4.46B | |
| Weighted average by Cap. | -0.01% | -1.26% | -9.82% | -14.39% |
| 2018 | 2019 | |
|---|---|---|
| Net sales | 19.14M 13.53M 11.84M 10.92M 10.09M 1.29B 19.46M 130M 51.24M 636M 50.82M 49.71M 2.19B | 22.25M 15.74M 13.76M 12.7M 11.73M 1.5B 22.62M 152M 59.57M 739M 59.08M 57.8M 2.54B |
| Net income | -36.02M -25.48M -22.28M -20.55M -18.98M -2.43B -36.63M -246M -96.44M -1.2B -95.65M -93.57M -4.11B | -126M -89.05M -77.89M -71.85M -66.36M -8.49B -128M -858M -337M -4.18B -334M -327M -14.38B |
| Net Debt | -15.55M -11M -9.62M -8.87M -8.19M -1.05B -15.81M -106M -41.63M -517M -41.29M -40.39M -1.78B | 5.22M 3.69M 3.23M 2.98M 2.75M 352M 5.31M 35.6M 13.98M 174M 13.87M 13.57M 597M |
Employees
-
Sector
Pharmaceuticals
Choose MarketScreener 
